WorldNews brief

FTC and seven states seek contempt ruling against Shkreli over pharma ban

LinkedInPostEmail
Save for later

Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions

Read the original report at theguardian.com.

Sources and context

theguardian.com

Source headline and summary supplied via Currents News API. First collected by NewsJaws on 2026-10-13. This is an automated news brief, not original NewsJaws reporting. Dates reflect the source publication. Feed delays may apply.

Powered by Currents News API